JGP Global Gestao de Recursos »

Blueprint Medicines shares owned by JGP Global Gestao de Recursos

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by JGP Global Gestao de Recursos from 13F filings

Historical chart of JGP Global Gestao de Recursos investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by JGP Global Gestao de Recursos consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by JGP Global Gestao de Recursos

Quarter filed Position value Share count Share price at filing
2024-09-30 $204k 2.2k 92.50

More positions owned by JGP Global Gestao de Recursos

New Gold Common Stock (NGD)
Stoneco Ltd-a Common Stock (STNE)
Rhythm Pharmaceuticals Common Stock (RYTM)
Eli Lilly & Co Common Stock (LLY)
Beigene Ltd- Adr
Incyte Corp Common Stock (INCY)
Unitedhealth Group Common Stock (UNH)
Itau Unibanco Hldng-pref Adr (ITUB)
Intuitive Surgical Common Stock (ISRG)
Thermo Fisher Scientific Common Stock (TMO)
Danaher Corp Common Stock (DHR)
Stryker Corp Common Stock (SYK)
Merck & Co Common Stock (MRK)
Elevance Health Common Stock (ELV)
Regeneron Pharmaceuticals Common Stock (REGN)

View all positions for JGP Global Gestao de Recursos

Top funds holding Blueprint Medicines

BlackRock
T. Rowe Price Associates
Jane Street
William Blair Investment Management
Geode Capital Management
Jpmorgan Chase & Co
Lord, Abbett & Co
Pictet Asset Management Holding SA
Invesco
American Century Companies
T. Rowe Price Investment Management
Susquehanna International
Charles Schwab Investment Management
Northern Trust
Man Group

View all funds holding Blueprint Medicines